In his wheelchair, Lee Marten, a 48-year-old sergeant with the Vancouver Police Department (VPD) on leave, operates a computer using a Neuralink brain implant. This cutting-edge technology allows him to control a digital keyboard with his mind, typing as fast as or faster than human fingers. Marten recently became one of the first Canadian ALS patients to undergo this procedure at University Health Network’s (UHN) Toronto Western Hospital, joining a small group of individuals worldwide testing the implant for those with ALS or spinal injuries.
Owned by Elon Musk, Neuralink has sparked controversy, with UHN receiving criticism for its involvement in the trial. Despite this, Marten views the implant as an opportunity to enhance his quality of life and contribute to scientific advancements that could benefit others facing similar challenges. Suffering from ALS, a progressive and incurable condition, Marten’s diagnosis has drastically altered his mobility, leaving him with limited hand movement and eventual loss of speech, walking, and breathing abilities.
Previously a law enforcement officer and military reservist, Marten’s journey with ALS began in 2022 with symptoms misattributed to a benign brain tumor. Following a series of medical challenges, including surgery to remove the tumor, his condition worsened, leading to the devastating ALS diagnosis. Determined to make the most of his remaining time, Marten underwent the Neuralink implant procedure, allowing him hope for improved communication and decision-making as his condition progresses.
Part of a global initiative, the Neuralink trial at UHN’s Toronto Western Hospital involves inserting over 1,000 tiny electrodes into the brain’s motor cortex to facilitate communication between the brain and external devices. Despite criticisms surrounding the trial, Dr. Andres Lozano, leading the neurosurgery team, emphasizes the potential benefits for patients with paralysis. Marten’s successful surgery marked a significant milestone, with his quick recovery and eagerness to test the device highlighting his resilience and determination in the face of adversity.
Looking ahead, Marten aims to stay engaged with his family and activities through the implant, cherishing moments with his children and exploring new possibilities facilitated by this innovative technology. Despite the challenges posed by ALS, Marten’s story exemplifies his unwavering spirit and determination to adapt and contribute positively to his life and those around him.
